GlassScriptPhysician profile
Richard Y Pak
NPI 1710968037
$17,476.86
in general payments reported to CMS, 2019-2025
63 companies · $2,882 in 2025
The $2,882 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $1,892 · 2021: $2,937 · 2022: $2,639 · 2023: $2,855 · 2024: $2,795 · 2025: $2,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,532.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,593.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,859.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,617.36 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $1,343.47 | 2019-2025 | Otezla, Repatha, Otezla |
| Glaxosmithkline, LLC. | $1,257.71 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $955.54 | 2019-2024 | Xarelto, Spravato |
| Pfizer INC. | $914.44 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $584.59 | 2019-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $429.69 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $349.54 | 2019-2025 | Jardiance, Kisunla, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $345.30 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $313.76 | 2020-2022 | |
| Exact Sciences Corporation | $312.38 | 2023-2025 | Cologuard Collection Kit |
| Intuitive Surgical, INC. | $283.14 | 2022 | |
| Allergan, INC. | $275.79 | 2019-2020 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.